(1)
Efficacy and Safety of FMX103 (1.5% Minocycline Foam) in the Treatment of Moderate to Severe Papulopustular Rosacea: Results from Two Phase 3 Randomized, Multicenter, Double Blind, Vehicle Controlled Studies. J of Skin 2019, 3 (2), 161. https://doi.org/10.25251/skin.3.2.1.